Oneness Biotech Co., Ltd. (LUX:ONES)
10.30
+0.20 (1.98%)
At close: Oct 21, 2025
Oneness Biotech Revenue
Oneness Biotech had revenue of 26.65M TWD in the quarter ending June 30, 2025, a decrease of -15.16%. This brings the company's revenue in the last twelve months to 112.57M, up 10.44% year-over-year. In the year 2024, Oneness Biotech had annual revenue of 117.93M with 35.89% growth.
Revenue (ttm)
112.57M TWD
Revenue Growth
+10.44%
P/S Ratio
257.20
Revenue / Employee
2.62M TWD
Employees
43
Market Cap
843.02M EUR
Revenue Chart
* This company reports financials in TWD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 117.93M | 31.14M | 35.89% |
| Dec 31, 2023 | 86.78M | -978.77M | -91.86% |
| Dec 31, 2022 | 1.07B | 999.79M | 1,520.24% |
| Dec 31, 2021 | 65.77M | 24.16M | 58.07% |
| Dec 31, 2020 | 41.61M | 28.13M | 208.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reinet Investments S.C.A. | 798.00M |
| Socfinaf | 663.01M |
| Socfinasia | 199.82M |
| CPI FIM | 182.41M |
| Luxempart | 97.19M |
| Fotex Holding S.E. | 42.87M |
| Velcan Holdings | 2.95M |